Newsroom

Ferring Pharmaceuticals Moves to Strengthen Growth with Appointment of Chief Medical and Chief Scientific Officers

SAINT PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today the appointment of Pascal Danglas, MD as Executive Vice President and Chief Medical Officer and Per Falk, MD, PhD as Executive Vice President and Chief Scientific Officer. Both appointments are effective as of February 1st.

Click here to read more

All Newsroom

Canada

Ferring Canada
200 Yorkland Boulevard, Suite 500
Toronto, Ontario, M2J 5C1 
Canada

Tel:  +1 416 490 0121 or +1 800 263 4057
Fax: 416 493 1692

Contact

Global Locator

Corporate Global Locator

You are leaving Ferring Canada!!!